LB-102

Schizophrenia

Manufacturer: LB Pharmaceuticals Inc
Regulatory submission: Not announced
Launch: Not announced
Last updated: October 8, 2026

Section

Product information and disease description Place of product in therapy

Disease description

144 evidence topics · 157 sources